Pharmaceutical - GlaxoSmithKline


Current filters:


Popular Filters

226 to 250 of 421 results

FDA advisory panel backs approval of COPD drug Breo Ellipta


Having earlier this week been presented with ambivalent briefing papers, the US Food and Drug Administration's…

Breo ElliptaGlaxoSmithKlineNorth AmericaPharmaceuticalRegulationRespiratory and PulmonaryTheravance

Adult vaccines market controlled by GSK and Merck


The adult vaccines market has been forecast to increase at a compound annual growth rate (CAGR) of 5.6%…

CervarixGardasilGlaxoSmithKlineMarkets & MarketingMerck & CoPfizerPharmaceuticalPrevnarVaccines

XenoPort reports Horizant "stockout" due to GSK manufacturing delays


USA-based XenoPort (Nasdaq: XNPT) says that UK pharma giant GlaxoSmithKline (LSE: GSK), who holds commercialization…

GlaxoSmithKlineHorizantMarkets & MarketingNorth AmericaPharmaceuticalProductionXenoPort

Briefs: Eddingpharm deal with GSK China for Tykerb; AEterna Zentaris and Ergomed link on AEZS-108


Chinese drugmaker Eddingpharm has entered into a collaboration agreement with UK pharma giant GlaxoSmithKline's…

AEterna ZentarisAEZS-108Asia-PacificErgomed Clinical ResarchGlaxoSmithKlineLicensingOncologyPharmaceuticalResearchTykerb

UK govt launches review of business-university growth opportunities, to be led by GlaxoSmithKline CEO


A review to boost growth opportunities for universities and businesses in the UK has been launched by…


GlaxoSmithKline and A*STAR's ICES to develop medicines for emerging markets


UK pharma giant GlaxoSmithKline (LSE: GSK) and Singapore-based A*STAR's Institute of Chemical and Engineering…


GlaxoSmithKline cleared for $91M flu vaccine plant in USA; Gets CRL on Q-Plan H5N1


UK pharma giant GlaxoSmithKline (LSE: GSK) and The Texas A&M University System (TAMUS) say that the US…

GlaxoSmithKlineNorth AmericaPharmaceuticalProductionQ-Plan H5N1RegulationVaccines

Positive NICE news for GSK's Revolade and InterMune's Esbriet


UK drugs watchdog the National Institute for Health and Clinical Excellence today (March 21) issued two…

BiotechnologyEsbrietEuropeGlaxoSmithKlineImmunologicalsInterMunePharmaceuticalPricingRegulationRespiratory and PulmonaryRevolade

GlaxoSmithKline and Abbott to start production in Ukraine


UK pharma giant GlaxoSmithKline (LSE: GSK) and the USA's Abbott (NYSE: ABT) are considering launching…

Anti-viralsAntibiotics and Infectious diseasesEuropeGlaxoSmithKlineIndarPharmaceuticalProductionVaccines

Anti-aging breakthrough could mean new drugs within five years


Drugs that combat aging may be available within five years, following landmark work led by an Australian…


Regulatory updates on GSK's albiglutide, Roche's hep C test, Activartis AV0113


UK pharma giant GlaxoSmithKline plc (LSE: GSK) says it has submitted a Marketing Authorization Application…

ActivartisalbiglutideAnti-viralsAV0113BiotechnologyDiabetesEperzanEuropeGlaxoSmithKlineNorth AmericaOncologyPharmaceuticalRegulationRoche

Clinical updates at ROI meeting on GSK's dolutegravir and Medivir's simeprevir


UK pharma giant GlaxoSmithKline (LSE: GSK) and Japanese drug major Shionogi (TYO: 4507) reported interim…


BRIC countries' breast cancer market to see 8% annual growth to 2017


The market for breast cancer therapies in the BRIC countries (Brazil, Russia, India and China) will grow…

GlaxoSmithKlineGlobalHerceptinMarkets & MarketingOncologyPharmaceuticalRocheTykerb

GAVI Alliance funds vaccines for cervical cancer in developing countries


More than 180,000 girls in eight developing countries are set to receive protection against the leading…

CervarixGardasilGlaxoSmithKlineHealthcareMerck & CoPharmaceuticalRest of the WorldVaccinesWomen's Health

Difficult European conditions hit GlaxoSmithKline, whose 4th-qtr profits slumped


UK pharma giant GlaxoSmithKline (LSE: GSK) blamed tough conditions in European markets for a decline…


226 to 250 of 421 results

Back to top